FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel derivatives of atazanavir sulfate - HIV protease inhibitor.
EFFECT: invention also relates to pharmaceutical compositions which possess antiviral activity with respect to HIV.
19 cl, 5 dwg, 11 tbl, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RESIQUIMOD DERIVATIVES | 2018 |
|
RU2808163C2 |
| TWO-SUBSTITUTED PYRAZOLE COMPOUNDS FOR DISEASE TREATMENT | 2017 |
|
RU2772212C2 |
| COMPOUNDS FOR TREATING PD-L1 DISEASES | 2020 |
|
RU2838028C2 |
| MMPL3 INHIBITORS, COMPOSITIONS BASED ON THEM AND WAYS OF THEIR APPLICATION | 2019 |
|
RU2795229C2 |
| MEK INHIBITORS AND THEIR THERAPEUTIC USE | 2021 |
|
RU2812929C1 |
| QUINAZOLINONE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2017 |
|
RU2730500C2 |
| TRICYCLIC TETRAHYDROISOQUINOLINE DERIVATIVE, METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINE | 2021 |
|
RU2830109C1 |
| HUMAN ALDOSTERONE SYNTHASE (CYP11B2) INHIBITORS | 2022 |
|
RU2811745C1 |
| CLASS OF CONDENSED RING COMPOUNDS AND THEIR PRODUCTION AND USE | 2021 |
|
RU2831125C1 |
| (ALPHA-SUBSTITUTED ARALKYLAMINO- AND HETEROARYLALKYLAMINO)PYRIMIDINYL- AND 1,3,5-TRIAZINYLBENZIMIDAZOLES, PHARMACEUTICAL COMPOSITIONS THEREOF AND USE THEREOF IN TREATING PROLIFERATIVE DISEASES | 2012 |
|
RU2608742C2 |
